Tampa-based Wellgistics Health, Inc., a healthcare
infrastructure company transforming the prescription drug ecosystem, announced its preliminary inclusion in the Russell 2000 and Russell 3000
Indexes, as part of the 2025 Russell US Indexes annual reconstitution.
FTSE
Russell released the preliminary list of additions and deletions to the Russell
2000 and Russell 3000 Indexes on Friday, May 23, with final inclusion expected
to take effect following the close of the U.S. equity market on Friday, June
27, 2025.
The Russell 3000 Index encompasses the 3,000 largest U.S.
companies by market capitalization, representing approximately 98% of the
investable U.S. equity market. The Russell 2000 Index is a subset of the
Russell 3000, measuring the performance of the small-cap segment.
These indexes
are widely used by investment managers and institutional investors for index
funds and as benchmarks for active investment strategies.
“Wellgistics Health’s preliminary inclusion in the
Russell 2000 and Russell 3000 indexes marks an important milestone in our
company’s journey,” said Brian Norton, CEO of Wellgistics Health.
“This recognition enhances our visibility among the broader investment
community, supports increased institutional interest and ownership in our
stock, and serves as strong validation of our team’s ability to execute on our
business plan and drive value to our shareholders.”